Stock Mumak

Stock Profile

Palantir Technologies

Palantir is among the leading providers of AI-powered data analysis. The company benefits from global AI adoption, rising defense spending, and growing demand for enterprise AI.

Stock Snapshot

Palantir_Logo
Table HeaderTable Header
CompanyPalantir Technologies
SectorTechnology
ThemeArtificial Intelligence / Big Data / Defense Technology / Enterprise Software
Business ModelDevelopment of AI-powered software platforms for data integration, data analysis, decision support, and operational applications for governments, defense agencies, and corporations
ISINUS69608A1088
Market Capitalizationapprox. 375 billion USD
UMBRELLA StatusWatchlist

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Palantir Technologies
Valuation Analysis

Valuation Analysis: Palantir Technologies

ISIN: US69608A1088

Palantir has evolved from a specialist in government software into one of the leading enterprise AI platforms. The company benefits from rising demand for artificial intelligence, defense technology, and data analytics. Commercial business in particular is growing dynamically. High margins, strong cash flows, and a debt-free balance sheet strengthen the investment case. The biggest challenge remains the stock’s ambitious valuation.
Compass 4 out of 5
More research

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – July 13-19, 2026

IBM's earnings warning rattles the stock markets. Why fundamental data, quarterly results, and company outlooks are once again the most
Next Update
Weekly Update

Weekly Market Overview – June 29–July 5, 2026

The healthcare sector remains in the lead, while technology and defense stocks are regaining strength. Positive impulses for the UMBRELLA
Next Update
Weekly Update

Weekly Market Overview – June 22-28, 2026

The UMBRELLA Strategy increased its focus on healthcare stocks and biotechnology. Technology showed a mixed performance, while defense stocks came
Next Update
Weekly Update

Weekly Market Overview – June 15-21, 2026

The UMBRELLA Strategy is divesting from energy stocks and further expanding its engagement in the healthcare and biotechnology sector.
Next Update